Clare Campbell-Cooper joined Fortrea in February 2020 and serves as its Global Head of Digital Health and Innovation. Clare has over 25 years of industry experience and is a recognized leader within the field of digital health. Clare has a wealth of experience encompassing many disciplines within clinical research and has held management positions within Data Management, Clinical Monitoring, Phase I Operations, Strategy and Planning, Project Management and, most recently, Digital Health.
Clare is an active member a number of boards and associations and sees that working in a pre-competitive environment is critical to helping drive change within the industry. Clare is passionate about how we can change clinical trials for the better and is a member of the Fortrea Environmental Sustainability Committee a founding member of the Fortrea Sustainable Future Chapter and Co-Chair on ACRO’s Sustainable Clinical Trials Committee. Clare sits on the Kings College London Scientific Advisory Board, Centre for Pharmaceutical Medicine Research and is a visiting lecturer at KCL.
In her role as Global Head of Digital Health and Innovation at Fortrea Clare is helping to change the face of how clinical research is developing. She specialises in strategy development for both internal and external partners. Clare’s special interest lies in the relationship between the caregiver and physician team and how the use of digital technology can augment this.
Rikin “Rik” Mehta—CEO & Co-Founder of Lactiga, a biotechnology company developing therapies from human milk antibodies for rare immunodeficiencies. Rik also teaches international drug law and regulation at Georgetown University Law Center and Mount St. Mary’s University, is a former FDA official, and made history as the first Indian-American nominee for U.S. Senate in New Jersey, where he also set a record for the highest number of votes ever received by his party’s candidate.
Akira Shibata leads the APAC region at Weights & Biases, the industry-standard platform for MLOps and LLMOps. He specializes in driving AI value creation across diverse industries, from generative AI to financial services. An accomplished entrepreneur and data scientist, Akira holds a Ph.D. in Physics from the University of London and has served as CEO of DataRobot Japan and COO of Qosmo, Inc. LinkedIn profile: https://www.linkedin.com/in/akirashibata/
Reto Cueni joined Syz Group in June 2025 as Chief Economist. He previously served as Chief Economist at Vontobel Group from 2020, having been part of Vontobel Asset Management’s Investment Strategy team since 2014 as a Senior Economist.
From 2009 to 2014, Reto worked as a researcher and lecturer in the Department of Economics at the University of Zurich. His academic work earned him a research fellowship from the Swiss National Science Foundation at Columbia University in New York. He began his career in finance as an equity analyst at Vontobel Equity Research in 2005. He continues to serve as a guest lecturer at the University of Zurich.
Anne Liebgott is founder of the online platform AW✚SWITZERLAND at americanswelcome.swiss, introducing wealth managers registered with the Securities and Exchange Commission in the United States dedicated to providing compliant wealth management services to US, Canadian, and Latin American citizens, residents, and expats. The platform also includes other wealth management-related services. In addition, Anne is the founder of AW❖UNITED KINGDOM and AW●ASIA PACIFIC | MIDDLE EAST. She also provides US-oriented, digital, and traditional marketing, communication, and business development strategies through her agency, Americom.
Experienced expert with a demonstrated history of working in IP Licensing, bussiness development and corporate operation in biotechology industry. Skilled in IP management, IP due diligence, Technology assessment，Patent licensing, Deal making, start-up making and Life Sciences. Strong IP legal & business professional with a Doctor of Philosophy (Ph.D.) focused in Pharmacology from Chinese Academy of Sciences.
